Genedata, a Danaher Corporation company and a leading provider of enterprise software solutions for biopharmaceutical R&D, announced a new release of Genedata Selector®. This updated solution automates next-generation sequencing (NGS) data processing and analysis.
The enhancement is designed to accelerate decision-making for more efficient quality control of advanced therapies in biopharma manufacturing. It improves data integrity by seamlessly connecting systems and facilitating efficient data transfer.
This technology breakthrough supports GMP-compliant workflows, ensuring high standards in therapeutic development. The Genedata Selector® platform continues to provide end-to-end solutions for biopharmaceutical R&D, from therapeutics design to process development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.